MedDataX Logo

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

NCT ID: NCT05121532

Last Updated: 2021-11-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients with Non-segmental Vitiligo before and after phototherapy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective study will include 30 patients with NSV, attending the Outpatient Clinics of Dermatology at Sohag University Hospitals, as well as 30 normal volunteers as control.

This study will be submitted for approval by Research and Ethical committees at Sohag Faculty of Medicine. An informed written consent will be obtained from each subject prior to participation in the study after full explanation of the procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitiligo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non segmental vitiligo

serum analysis

Group Type ACTIVE_COMPARATOR

Interleukin-15 and Interleukin-22

Intervention Type DIAGNOSTIC_TEST

Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo

normal volunteer

serum analysis

Group Type ACTIVE_COMPARATOR

Interleukin-15 and Interleukin-22

Intervention Type DIAGNOSTIC_TEST

Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interleukin-15 and Interleukin-22

Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Patients suffering from non segmental vitiligo.

* Patients not on medical treatment or phototherapy for vitiligo in the last 3 months.

Exclusion Criteria

* • Patients with systemic or cutaneous inflammatory disorders.

* Patients on treatment for vitiligo in last 3 months.
* Pregnant and lactating patients.
* Patients with history of diabetes.
* Patients with history of autoimmune diseases.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samah Saeed Badrous

resident doctor at dermatology department balina central hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-21-11-12

Identifier Type: -

Identifier Source: org_study_id